The activity of MMP9 and MMP2 can break down the BBB via directly degrading tight junction proteins such as occludin and claudin-5, leading to reversible degradation early after the onset of ischemia and initiating vasogenic edema [46, 47]. This evidence concerns the gene CLDN5 and ischemia.